Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2026 Financial Results

Click here to view

Presentation

Poster: SOD1 Gene Repression Mediated by Zinc Finger Repressors (ZFRs) as a Therapeutic Approach for SOD1-Mediated ALS

Download PDF